Innovative Alzheimer therapy: A new license agreement between BioArctic and Eisai on back-up program to BAN2401
BioArctic Neuroscience AB announces today that a new license agreement has been signed between BioArctic and the Japanese pharmaceutical company Eisai Co., Ltd.